127 related articles for article (PubMed ID: 38281770)
1. Principal stratification analysis of noncompliance with time-to-event outcomes.
Liu B; Wruck L; Li F
Biometrics; 2024 Jan; 80(1):. PubMed ID: 38281770
[TBL] [Abstract][Full Text] [Related]
2. Multiply robust estimation of principal causal effects with noncompliance and survival outcomes.
Cheng C; Guo Y; Liu B; Wruck L; Li F; Li F
Clin Trials; 2024 May; ():17407745241251773. PubMed ID: 38813813
[TBL] [Abstract][Full Text] [Related]
3. Estimation of causal effects in clinical endpoint bioequivalence studies in the presence of intercurrent events: noncompliance and missing data.
Lou Y; Jones MP; Sun W
J Biopharm Stat; 2019; 29(1):151-173. PubMed ID: 29995564
[TBL] [Abstract][Full Text] [Related]
4. Bayesian phase II clinical trial design with noncompliance.
Ren T; Shen W; Zhang L; Zhao H
Stat Med; 2021 Sep; 40(20):4457-4472. PubMed ID: 34050539
[TBL] [Abstract][Full Text] [Related]
5. A refreshing account of principal stratification.
Mealli F; Mattei A
Int J Biostat; 2012; 8(1):. PubMed ID: 22611592
[TBL] [Abstract][Full Text] [Related]
6. Principal stratification in causal inference.
Frangakis CE; Rubin DB
Biometrics; 2002 Mar; 58(1):21-9. PubMed ID: 11890317
[TBL] [Abstract][Full Text] [Related]
7. Bayesian sequential monitoring design for two-arm randomized clinical trials with noncompliance.
Shen W; Ning J; Yuan Y
Stat Med; 2015 Jun; 34(13):2104-15. PubMed ID: 25756852
[TBL] [Abstract][Full Text] [Related]
8. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
Wang Y; Berlin JA; Pinheiro J; Wilcox MA
Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
[TBL] [Abstract][Full Text] [Related]
9. Applying optimal model selection in principal stratification for causal inference.
Odondi L; McNamee R
Stat Med; 2013 May; 32(11):1815-28. PubMed ID: 23042517
[TBL] [Abstract][Full Text] [Related]
10. Joint modeling compliance and outcome for causal analysis in longitudinal studies.
Gao X; Brown GK; Elliott MR
Stat Med; 2014 Sep; 33(20):3453-65. PubMed ID: 23576159
[TBL] [Abstract][Full Text] [Related]
11. Inference on latent factor models for informative censoring.
Ungolo F; van den Heuvel ER
Stat Methods Med Res; 2022 May; 31(5):801-820. PubMed ID: 35077263
[TBL] [Abstract][Full Text] [Related]
12. Handling parametric assumptions in principal causal effect estimation using Gaussian mixtures.
Jo B
Stat Med; 2022 Jul; 41(16):3039-3056. PubMed ID: 35611438
[TBL] [Abstract][Full Text] [Related]
13. An introduction to causal modeling in clinical trials.
Bellamy SL; Lin JY; Ten Have TR
Clin Trials; 2007; 4(1):58-73. PubMed ID: 17327246
[TBL] [Abstract][Full Text] [Related]
14. A Bayesian nonparametric approach for evaluating the causal effect of treatment in randomized trials with semi-competing risks.
Xu Y; Scharfstein D; Müller P; Daniels M
Biostatistics; 2022 Jan; 23(1):34-49. PubMed ID: 32247284
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of estimands in clinical trials with imperfect compliance.
Chen H; Heitjan DF
Int J Biostat; 2024 May; 20(1):57-67. PubMed ID: 37365674
[TBL] [Abstract][Full Text] [Related]
16. Clarifying selection bias in cluster randomized trials.
Li F; Tian Z; Bobb J; Papadogeorgou G; Li F
Clin Trials; 2022 Feb; 19(1):33-41. PubMed ID: 34894795
[TBL] [Abstract][Full Text] [Related]
17. Causal inference for time-to-event data with a cured subpopulation.
Wang Y; Deng Y; Zhou XH
Biometrics; 2024 Mar; 80(2):. PubMed ID: 38708764
[TBL] [Abstract][Full Text] [Related]
18. Performance of statistical methods for analysing survival data in the presence of non-random compliance.
Odondi L; McNamee R
Stat Med; 2010 Dec; 29(29):2994-3003. PubMed ID: 20963732
[TBL] [Abstract][Full Text] [Related]
19. Assessing the ratio of means as a causal estimand in clinical endpoint bioequivalence studies in the presence of intercurrent events.
Lou Y; Jones MP; Sun W
Stat Med; 2019 Nov; 38(27):5214-5235. PubMed ID: 31621943
[TBL] [Abstract][Full Text] [Related]
20. Surrogacy assessment using principal stratification with multivariate normal and Gaussian copula models.
Taylor JM; Conlon AS; Elliott MR
Clin Trials; 2015 Aug; 12(4):317-22. PubMed ID: 25490988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
